Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.
about
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symportersPersistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsDevelopments in the treatment of hemophilia B: focus on emerging gene therapyImproved retroviral vectors for gene transfer and expression.Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogsGene therapy for the hemophilias.Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease.Construction of retroviral vectors with improved safety, gene expression, and versatility.Canine hemophilia B resulting from a point mutation with unusual consequencesDeficient repair of the transcribed strand of active genes in Cockayne's syndrome cells.Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.Expression of functional c-kit receptors rescues the genetic defect of W mutant mast cellsRepression of retrovirus-mediated transgene expression by interferons: implications for gene therapyInternal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions.Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy.Expression of human factor IX in mice after injection of genetically modified myoblastsGene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivoGenetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes.Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia BLong-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer.Coagulation Factor IX for Hemophilia B Therapy.
P2860
Q24315645-90096970-5382-4952-899C-D4F8D2BACB9EQ24683259-CC21BB03-7000-482D-9798-F1D2A6AEDD55Q26823376-390A7923-CE88-449C-B7E7-10311176B5D0Q29614384-34A9B3C6-0BC2-4501-B82E-11F00F5CF2FBQ33671665-A912EB08-C56F-4731-B7BE-85054B633301Q33723486-82721BEA-A10F-4DEC-9160-4D121E2FB9C4Q33739384-E8386767-FAD4-4F42-A867-82487BB8EFDCQ33930132-220C5BE8-5C80-477C-B331-2555ACF32DCBQ34069096-E8B2B6B5-6C61-4B76-98E0-2AB508B26A48Q34326780-22C998EC-209E-4FF2-85BF-A7F101C58F4CQ34348395-35BACA60-BC5A-4C9E-8352-A04367027152Q35157358-754C4E93-1CB9-49FA-8910-B5DDFC791710Q35934945-893B79ED-6590-4FEB-90EB-5A965CB569F2Q36548693-ECB07037-6426-4873-84D9-9B470F8567BDQ36797849-B6373819-5D4D-4305-94B0-4C48173B28EAQ36823389-5E18FA02-04FB-4C71-8358-3721EFD41663Q36950396-6BEFF788-2BC2-4F8E-95F3-BC01932A3281Q37300317-B80C04C8-C9BC-4BEC-BEEC-82F28767CDBDQ37401979-E1764ECA-5AC9-4919-82F5-5367CDC2377FQ37518848-51A8A6B6-A3A3-4953-9E41-2F69704E7E7BQ37594306-E86BD384-AE69-4803-91E1-C32B00F9339AQ37723721-27B18ECD-571D-4BE5-A5F7-DF7E112D4A7CQ42256024-15B246C9-FCFD-4483-8604-29A3F882934C
P2860
Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Production of human factor IX ...... tial therapy for hemophilia B.
@en
Production of human factor IX ...... tial therapy for hemophilia B.
@nl
type
label
Production of human factor IX ...... tial therapy for hemophilia B.
@en
Production of human factor IX ...... tial therapy for hemophilia B.
@nl
prefLabel
Production of human factor IX ...... tial therapy for hemophilia B.
@en
Production of human factor IX ...... tial therapy for hemophilia B.
@nl
P2093
P921
P1433
P1476
Production of human factor IX ...... ntial therapy for hemophilia B
@en
P2093
P304
P407
P577
1989-02-01T00:00:00Z